| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G |
| 12 Nov 2026 | 10-Q |
| 12 Nov 2026 |
8-K: Results of Operations and Financial Condition
Ipsoprubart Advancing in Global Registrational Program as Potential First Treatment for sHLH Broadly; Enrollment Completion Expected in Second Half of 2027 |
| 10 Nov 2026 |
Form 4: Gordon Carl L, Director
Bought 49,416 shares ($388K) · Bought 20,000 shares ($165K) · Bought 22,700 shares ($192K) |
| 10 Nov 2026 |
Form 4: Orbimed Advisors Llc, Director and 2 others
Bought 49,416 shares ($388K) · Bought 20,000 shares ($165K) · Bought 22,700 shares ($192K) |
| 05 Nov 2026 |
Form 4: Gordon Carl L, Director
Bought 245,113 shares ($1.93M) · Bought 71,367 shares ($537K) · Bought 156,091 shares ($1.14M) |
| 05 Nov 2026 |
Form 4: Orbimed Advisors Llc, Director and 2 others
Bought 245,113 shares ($1.93M) · Bought 71,367 shares ($537K) · Bought 156,091 shares ($1.14M) |
| 29 Oct 2026 | SCHEDULE 13G |
| 28 Sep 2026 | SCHEDULE 13G |
| 28 Sep 2026 | SCHEDULE 13G |
| 25 Sep 2026 | SCHEDULE 13D |
| 23 Sep 2026 |
Form 4: Orbimed Advisors Llc, Director and 2 others
Received 5,551,837 shares by conversion · Bought 1,333,333 shares ($20M) |
| 23 Sep 2026 |
Form 4: Gordon Carl L, Director
Received 5,551,837 shares by conversion · Bought 1,333,333 shares ($20M) |
| 21 Sep 2026 |
Form 3: Westlake BioPartners Fund I, L.p., 10% owner and 3 others
Holds 3,527,136 shares of Common Stock |
| 21 Sep 2026 |
Form 4: Koe Gary S., Chief Technical Officer
Received 63,656 shares by conversion |
| 21 Sep 2026 |
Form 4: Stagliano Nancy, Director
Received 255,635 shares by conversion |
| 21 Sep 2026 |
Form 4: Parry Graham, Chief Scientific Officer
Received 85,504 shares by conversion |
| 21 Sep 2026 |
Form 4: Dong Quehuong (Kathy), Director
Received 455,484 shares by conversion |
| 21 Sep 2026 | S-8 |
| 21 Sep 2026 |
8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Other Events
Electra Therapeutics, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify that: |
Loading...